• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.62%

    AMAG Pharmaceuticals, Inc. (AMAG)

    -NasdaqGS
    26.52 Down 0.91(3.32%) Apr 29, 4:00PM EDT
    |After Hours : 25.95 Down 0.57 (2.15%) Apr 29, 7:29PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
    Total Revenue 108,735   96,152   123,884   89,505  
    Cost of Revenue25,447  22,349  19,679  21,026  
    Gross Profit 83,288   73,803   104,205   68,479  
    Operating Expenses
    Research Development7,897  19,809  8,184  6,988  
    Selling General and Administrative50,255  46,141  31,801  32,112  
    Non Recurring2,463  9,238  3,096  571  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 22,673   (1,385) 61,124   28,808  
    Income from Continuing Operations
    Total Other Income/Expenses Net537  (19,107)374  71  
    Earnings Before Interest And Taxes23,210  (20,492)61,498  28,879  
    Interest Expense18,457  14,222  10,205  10,367  
    Income Before Tax4,753  (34,714)51,293  18,512  
    Income Tax Expense(2,448)(14,130)18,035  5,608  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops7,201  (20,584)33,258  12,904  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 7,201   (20,584) 33,258   12,904  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 7,201   (20,584) 33,258   12,904  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.